Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urologic Neoplasms × Control Groups × Clear all

Sponsor

Conditions

Breast Neoplasms 2 Sleep Initiation and Maintenance Disorders 1 Neoplasms 1 Mobility Limitation 1 Healthy 1 Disease 1 Colorectal Neoplasms 1 Alzheimer Disease 1

Interventions

Trastuzumab 3 Sugammadex 2 Neostigmine 2 Cisplatin 2 valrubicin 1 tucatinib 1 pembrolizumab 1 niraparib 1 enfortumab vedotin 1 avelumab 1 atezolizumab 1 Surveys and Questionnaires 1 Sunitinib 1 Standard of Care 1 Rocuronium 1 Pemetrexed 1 Paclitaxel 1 Nephroureterectomy 1 Neoadjuvant Therapy 1 Mitomycin 1 Lymph Node Excision 1 Glycopyrrolate 1 Gemcitabine 1 GSK-3326595 1 Fulvestrant 1 Docetaxel 1 Cetuximab 1 Afatinib 1 Administration, Intravesical 1 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡